Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Clinical trial NCT00315237 · COMPLETED

Trial details

NCT number: NCT00315237
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transitional Cell Carcinoma of the Urothelial Tract Bladder Cancer Bladder Neoplasms

Start date: 2005-07-01
Primary completion: 2008-01-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.